Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Cousins

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 2012
NHS Diabetes guideline for the perioperative management of the adult patient with diabetesK Dhatariya, N Levy, A Kilvert, et al.
Veterinary Microbiology|May 5, 1999
Comparison of serological tests and faecal culture for the detection of Mycobacterium avium subsp. paratuberculosis infection in cattle and analysis of the antigens involvedM P Reichel, R Kittelberger, M E Penrose, et al.
Biochemistry|December 6, 1994
Lysine 182 of endothelin B receptor modulates agonist selectivity and antagonist affinity: evidence for the overlap of peptide and non-peptide ligand binding sitesJ A Lee, J A Brinkmann, E D Longton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 1, 2001
Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclatureJ W Dale, D Brittain, A A Cataldi, et al.
Scientific Reports|November 17, 2025
Investigating fucoidan blend supplementation and resistance training in humans: a parallel randomized controlled trial designStephen D Cousins, Samantha T C Kucewicz, Daniel W T Wundersitz, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimeticsR M Keenan, W H Miller, L S Barton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 1999
Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonistK W Ward, L M Azzarano, W E Bondinell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal modelsR S Ames, D Lee, J J Foley, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonistsR M Keenan, W H Miller, M A Lago, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis modelR M Keenan, M A Lago, W H Miller, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 2012
NHS Diabetes guideline for the perioperative management of the adult patient with diabetesK Dhatariya, N Levy, A Kilvert, et al.
Veterinary Microbiology|May 5, 1999
Comparison of serological tests and faecal culture for the detection of Mycobacterium avium subsp. paratuberculosis infection in cattle and analysis of the antigens involvedM P Reichel, R Kittelberger, M E Penrose, et al.
Biochemistry|December 6, 1994
Lysine 182 of endothelin B receptor modulates agonist selectivity and antagonist affinity: evidence for the overlap of peptide and non-peptide ligand binding sitesJ A Lee, J A Brinkmann, E D Longton, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 1, 2001
Spacer oligonucleotide typing of bacteria of the Mycobacterium tuberculosis complex: recommendations for standardised nomenclatureJ W Dale, D Brittain, A A Cataldi, et al.
Scientific Reports|November 17, 2025
Investigating fucoidan blend supplementation and resistance training in humans: a parallel randomized controlled trial designStephen D Cousins, Samantha T C Kucewicz, Daniel W T Wundersitz, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 1999
Orally bioavailable nonpeptide vitronectin receptor antagonists containing 2-aminopyridine arginine mimeticsR M Keenan, W H Miller, L S Barton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 26, 1999
Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonistK W Ward, L M Azzarano, W E Bondinell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal modelsR S Ames, D Lee, J J Foley, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonistsR M Keenan, W H Miller, M A Lago, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis modelR M Keenan, M A Lago, W H Miller, et al.
Pageof 7